Roxy Darwina

 
Picture of Roxy Darwina
by Roxy Darwina - Thursday, 19 June 2014, 11:00 pm
Anyone in the world
Due to the health risks allegedly caused by Benicar (olmesartan), affected patients started filing benicar lawsuits due to the drug’s alleged negative side effects particularly sprue-like enteropathy. The connection between Benicar and sprue-like enteropathy was first uncovered by clinical experts at the Mayo Clinic in Rochester, Minnesota. benicar lawsuit ~The link between sprue-like enteropathy and Benicar was first discovered by researchers at the Mayo Clinic in Rochester.~The experts at Mayo Clinic in Rochester first discovered the linkage between Benicar and sprue-like enteropathy. The researchers were originally studying Benicar in connection with celiac disease but found that gastrointestinal symptoms significantly decreased after the discontinuation of their treatment with the drug.~ They were initially studying Benicar’s link to celiac disease but they discovered that gastrointestinal symptoms drastically decreased after stopping the intake of Benicar.~These experts were originally looking into Benicar’s connection with celiac disease. However, they later found that the gastrointestinal symptoms significantly lessened after discontinuing the Benicar treatment. The Mayo Clinic’s study involved 22 patients who were all prescribed with Benicar for their hypertension.~This research from Mayo Clinic involved 22 patients who were all prescribed Benicar for their high blood pressure.~A total of 22 patients who were using Benicar participated in this Mayo Clinic study. Suspecting this was more than a mere coincidence, the clinical experts asked the patients to stop their usage of Benicar.~Assuming that this was more a coincidence, the researchers asked the patients to discontinue the use of Benicar.~Putting in mind that this was more than a coincidence, the medical experts asked the patients to stop taking Benicar. After discontinuing Benicar, the patients confirmed that the chronic diarrhea, vomiting, weight loss and other intestinal inflammation symptoms improved.~After stopping the Benicar intake, all patients confirmed that the chronic diarrhea, vomiting, weight loss and other intestinal inflammation symptoms decreased.~After they stopped taking Benicar, the patients said that the chronic diarrhea, vomiting, weight loss and other intestinal inflammation symptoms lessend. Moreover, after discontinuing Benicar, the patients gained an average of 27 pounds.~Furthermore, the patients gained about 27 pounds after they stopped taking the drug.~Also, the patients gained around 27 pounds after they discontinued the use of Benicar. With this, the U.S. Food and Drug Administration (FDA) issued a public health warning on July 4, 2013 that Benicar may cause sprue-like enteropathy. ~Due to this, the U.S. Food and Drug Administration (FDA) released a warning on July 4 2013 saying that Benicar may cause sprue-like enteropathy.~Consequently, on July 4, 2013, the U.S. Food and Drug Administration (FDA) issued a safety warning saying that Benicar use may lead to sprue-like enteropathy. Based on the FDA warning, symptoms of sprue-like enteropathy include severe, chronic diarrhea with substantial weight loss.~According to the warning, symptoms of sprue-like enteropathy are severe, chronic diarrhea with significant weight loss.~The warning also indicated that the symptoms of sprue-like enteropathy include severe, chronic diarrhea with extensive weight loss. Moreover, the FDA approved changes to the labels of Benicar to include this concern.~Furthermore, the FDA approved label changes for Benicar to include this issue.~Additionally, due to this issue, the FDA approved label changes for Benicar. Benicar is an angiotensin receptor blocker (ARB) used to treat hypertension.~ Benicar is an angiotensin receptor blocker (ARB) used to treat high blood pressure.~ Benicar is an angiotensin receptor blocker (ARB) prescribed for the treatment of hypertension. It has been prescribed to help lower high blood pressure in patients by helping the blood vessels in the body to widen and preventing constriction of the vessels.~ This drug has been prescribed to lower high blood pressure in patients by helping the blood vessels in the body to widen and preventing constriction of the vessels.~Benicar has been prescribed to lower high blood pressure among patients by helping the blood vessels in the body to widen and preventing constriction of the vessels. It is sometimes taken alongside other blood pressure medicines.~ It is sometimes taken together with other blood pressure drugs. ~ In some instances, it is taken alongside other blood pressure medicines. Benicar is currently available on the market in two tablet forms: Benicar (olmesartan medoxomil) and Benicar HCT (olmesartan medoxomil and hydrochlorothiazide).~At present, Benicar is available on the market in two tablet forms: Benicar (olmesartan medoxomil) and Benicar HCT (olmesartan medoxomil and hydrochlorothiazide).~ Benicar is presently available on the market in two tablet forms: Benicar (olmesartan medoxomil) and Benicar HCT (olmesartan medoxomil and hydrochlorothiazide). Both Benicar and Benicar HCT have been widely prescribed by doctors since their approval by the FDA in 2002 and 2003, with 10.6 million prescriptions written for Benicar in the year 2012 alone.~ The two have been extensively prescribed by doctors since their approval by the FDA in 2002 and 2003, with 10.6 million prescriptions written for Benicar in 2012 alone.~ The two forms have been usually prescribed by doctors since their approval by the FDA in 2002 and 2003, with 10.6 million prescriptions written for Benicar in the year 2012 alone. Actually, Benicar is just one of the eight marketed ARB drugs.~Benicar is only one of the eight marketed ARB medications.~Benicar is just one of the eight ARB medicines available in the market. However, it is the only one linked to sprue-like enteropathy.~ But it is the only one connected to sprue-like enteropathy.~ However, it is the only one linked to sprue-like enteropathy. Sprue-like enteropathy, a gastrointestinal (GI) condition where impairment happens to the intestinal villi that may cause several severe symptoms, including gastrointestinal issues, including rapid weight loss, chronic diarrhea, fatigue, abdominal pain, nausea, vomiting, bloating, and anemia. Sprue-like enteropathy, a gastrointestinal (GI) disease where injury happens to the intestinal villi leading to a number of severe symptoms, including gastrointestinal issues, including rapid weight loss, chronic diarrhea, fatigue, abdominal pain, nausea, vomiting, bloating, and anemia. ~ Sprue-like enteropathy, a gastrointestinal (GI) health disease where harm happens to the intestinal villi resulting in several severe symptoms, including gastrointestinal issues, including rapid weight loss, chronic diarrhea, fatigue, abdominal pain, nausea, vomiting, bloating, and anemia. It also causes the lining of the intestines to lose its texture and makes it difficult to absorb nutrients.~ This disease also makes the lining of the intestines to lose its texture and makes it hardt to take in nutrients.~ Also, this condition causes the lining of the intestines to lose its texture and makes it difficult to suck up nutrients. This condition results in serious malnourishment, which may cause other digestive issues.~It further leads to malnourishment and other digestive problems.~ Sprue-like enteropathy may also cause malnourishment and other digestive diseases. Medical resources say that sprue-like enteropathy may be easily overlooked by physicians as its symptoms are often misdiagnosed for symptoms associated with Celiac disease, an adverse health condition in which the body cannot break down gluten.~ According to medical resources, sprue-like enteropathy may be simply disregarded by doctors as its symptoms are frequently misdiagnosed for symptoms associated with Celiac disease, an adverse health condition wherein the body cannot break down gluten.~ Based on medical resources, sprue-like enteropathy may be easily unseen by physicians as its symptoms are usually misdiagnosed for symptoms associated with Celiac disease, an health disease where the body cannot break down gluten.